Welcome to our dedicated page for MEDICAL CARE TECHS news (Ticker: MDCE), a resource for investors and traders seeking the latest updates and insights on MEDICAL CARE TECHS stock.
Medical Care Technologies Inc. develops and commercializes artificial intelligence applications across consumer software, imaging analysis, healthcare-oriented pre-screening and collectibles authentication. News about MDCE centers on its AI technology stack, including Snapshot Recipes, a mobile recipe application with AI-generated food and beverage content, and Real Game Used, a subsidiary developing a patent-pending AI authentication platform for sports memorabilia.
Company updates also cover AI imaging initiatives for dermatological analysis, wellness monitoring, product verification and automated quality control, as well as capital and asset-monetization activity through Infinite Auctions. Recurring announcements describe product redesigns, commercialization pathways, subsidiary activity, mobile-app user growth initiatives, and enterprise API or visual analytics use cases.
Medical Care Technologies (OTCID:MDCE) highlighted the agricultural defense capabilities of its proprietary AI vision platform StrainScan Pro, designed for early detection of pests, crop illness, crop stress, and visual quality threats in the multi-trillion-dollar global agriculture sector. The system performs rapid, on-device visual analysis at the field, packing, or handling level.
According to the company, StrainScan Pro is optimized for deployment on iPad Air devices, providing a portable enterprise solution that does not require fixed industrial infrastructure. The platform is being advanced as a flexible tool for both regulated retail quality verification and large-scale agricultural monitoring. Medical Care Technologies continues to develop AI vision applications across multiple high-value verticals while generating revenue through its operating subsidiaries.
Medical Care Technologies (OTCID:MDCE) unveiled the strategic role of its StrainScan Pro platform, a proprietary AI vision solution aimed at enhancing visual quality verification in regulated cannabis retail and large-scale agriculture. The system provides rapid, on-device analysis to support strain consistency, potency-related visual indicators, and quality checks for licensed operators.
According to the company, the same computer-vision architecture targets broader agricultural needs such as early pest and crop-illness detection and identification of visual anomalies that may indicate bacterial or quality issues. Deployed on iPad Air devices, StrainScan Pro is intended for use across farms, packing facilities, distribution points, and retail locations, enabling freshness and quality tracking from field to final destination. Medical Care Technologies emphasizes that it develops and commercializes AI vision software and does not handle cannabis or plant products directly, while continuing to expand AI solutions across health, wellness, nutrition, lifestyle, and enterprise imaging.
Medical Care Technologies (OTC Pink: MDCE) is promoting its already-launched StrainScan Pro, an AI-powered computer-vision platform aimed at licensed, multi-location cannabis dispensary operators. The software provides rapid visual strain identification and quality verification and is specifically optimized for deployment on Apple iPad Air devices, enabling on-device analysis without fixed industrial systems.
According to the company, StrainScan Pro targets the multi-billion-dollar U.S. cannabis retail sector by offering mobile, scalable tools to support consistent operations across locations. Medical Care Technologies emphasizes that it develops AI vision technology and does not cultivate, process, distribute, or sell cannabis, and notes it also generates revenue through subsidiaries Infinite Auctions and Real Game Used.
Medical Care Technologies (OTC Pink: MDCE) announced it is positioning its AI-powered StrainScan Pro visual intelligence platform for the global foodservice sector, targeting restaurants, commercial kitchens, and high-volume food operations. The software is optimized for enterprise deployment as a portable, on-device solution on iPad Air hardware.
According to the company, this model supports rapid, scalable visual quality monitoring without complex fixed systems, aimed at improving inspection speed and consistency across single and multi-unit locations. The move extends the company’s strategy of applying its AI vision technology to high-value verticals while continuing to generate revenue through subsidiaries Infinite Auctions and Real Game Used.
Medical Care Technologies (OTC Pink: MDCE) announced the expansion of its proprietary AI vision platform StrainScan Pro into agricultural quality control, targeting enterprise deployment on iPad Air devices across farming and post-harvest operations. The software is designed for on-device visual quality grading and produce inspection in fields, packing facilities, and post-harvest environments.
According to Medical Care Technologies, this move aligns with its strategy to deploy AI vision across high-value verticals while maintaining revenue generation through subsidiaries Infinite Auctions and Real Game Used. The company highlights the multi-trillion-dollar global agriculture market, estimated near $5 trillion, as a key opportunity.
Medical Care Technologies (OTCID:MDCE) announced the public launch of StrainScan Pro, an AI-powered visual intelligence platform initially targeting cannabis dispensaries for strain identification and analysis. The system uses the company’s proprietary AI vision technology to provide rapid, accurate visual assessment.
According to the company, StrainScan Pro’s underlying computer-vision architecture is designed for broader quality-control applications in agriculture, food distribution, restaurants, grocery supply chains, and processing facilities. The launch aligns with Medical Care Technologies’ strategy to deploy its AI vision platform across multiple verticals while supporting non-dilutive capital generation through subsidiaries Infinite Auctions and Real Game Used.
Medical Care Technologies (OTC Pink: MDCE) reported ongoing rigorous testing of its MDCE Melanoma Scan Beta AI imaging platform as of August 3, 2026. The company is conducting structured evaluation and model training using multi-phase testing protocols that emphasize image quality, consistency, and performance across varied datasets, aiming to refine its proprietary AI vision systems.
In parallel, Medical Care Technologies continues to operate a diversified business model with revenue-generating subsidiaries and consumer applications. The company is evaluating selective partnerships and potential brand acquisitions aligned with its software development, AI vision, and digital platform capabilities, while seeking to balance technical development, monetization, and strategic growth.
Medical Care Technologies (OTC Pink:MDCE) reported broader monetization of its technology portfolio, generating revenue from mobile apps, enterprise web solutions, AI vision systems, and backend logistics software while advancing its core medical imaging tools, including the MDCE Melanoma Scan Beta and MDCE Wound Monitor applications.
According to Medical Care Technologies, its Snapshot Recipes app is nearing 1,000 users, Infinite Auctions has processed nearly $25 million in lifetime sales, and Real Game Used has authenticated over $35 million in sports and entertainment memorabilia, supporting a diversified, revenue-focused model complemented by ongoing AI model training and potential partnership and brand acquisition evaluations.
Medical Care Technologies (OTC PINK:MDCE) reported a major technical progression of its proprietary AI vision platform, now significantly beyond the scope of its July 2025 U.S. Provisional Patent Application No. 63/854,935. The company therefore chose not to continue prosecuting that earlier filing, stating its technology has leapfrogged the original disclosures.
MDCE is focusing on newly trained, continuously learning AI models that adapt to changing data and environments. These models are intended to support consumer, medical-grade, and enterprise-level visual identification, quality control, and imaging analysis, spanning healthcare imaging, agricultural quality monitoring, and broader industrial visual analysis applications.
Medical Care Technologies (OTC PINK:MDCE) reported that its wholly owned subsidiary, Infinite Auctions, completed an online auction using the company's new proprietary auction software platform. The event generated approximately $125,000 in proceeds from sales of company-owned inventory.
According to Medical Care Technologies, the funds will be used to reduce outstanding debt and support ongoing operations tied to its AI vision technology platforms. Management highlighted that this represents non-dilutive capital raised through liquidation of assets as the company works to strengthen its balance sheet and advance AI-focused technology initiatives across its diversified portfolio.